Cybonix Genesis  Collectibles - dapp.expert
Cybonix Genesis
Category: Collectibles Blockchain: Ethereum Language: English Platform: Web

Cybonix Genesis - collection of unique cyborgs

Cybonix Genesis — a set of 1500 NFTs that will be released on the Ethereum blockchain.

Cybonix Genesis - collector's edition with unique characters

The year is 2777, and the Cybonic Cyborgs have been expelled from their home planet of Saigonia. Only 1,500 of the most elite Cybonix survived the initial attack, and they retreated to their top-secret space facility on the dark side of Vordon's moon.

The Cybonix Genesis Metaverse has created and cloned 1,500 cyborgs through online programming, known as CYBONIX. The cyborgs build and train to take revenge on the mystical warlords who brutally ransacked their world.

Stages of project development:

Phase 1 The very first NFT collection features 1,500 3D male cyborgs, ready to take on the Eldor Mystics in the war to reclaim Cygonia.
Phase 2 Education and access to resources to help you to become a crypto trader and investor.
Phase 3 Cybonix trading alerts will be available exclusively to holders and provide detailed information on the most popular cryptocurrencies and alternative coins.
Phase 4 The second NFT collection, representing 4500 TBA.
Phase 5 The launch of an exclusive marketplace for owners will provide cyborgs with the ability to redeem events, utilities, merchandise, whitelist other projects, and more.
Phase 6 Your cyborg will be integrated into Play 2 Earn games like Swift Shootout Battle Royale Game.

The developers are creating a new generation of cyborg fighters. Join the community on Twitter and Discord to find out how you can be part of this generation.

Dapp Cybonix Genesis
Cybonix Genesis dapps

Cybonix Genesis - collection of unique cyborgs Statistics

Users
24 hr: 1
0%
Total: 1.796
(2400 days)
ATH: 651
(Mar 7, 2022)
Volume
24 hr: 0
0%
Total: 594.958
(2400 days)
ATH: 365.787
(Mar 7, 2022)
Transactions
24 hr: 1
0%
Total: 2.398
(2400 days)
ATH: 999
(Mar 7, 2022)
0

Reaction to the article

Reviews (0)